Business Description
PharmAbcine Inc
ISIN : KR7208340000
Description
Financial Strength
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 4.66 | |||||
Equity-to-Asset | 0.74 | |||||
Debt-to-Equity | 0.19 | |||||
Debt-to-EBITDA | -0.42 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | 3.63 | |||||
Beneish M-Score | -1.38 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -0.8 | |||||
3-Year EBITDA Growth Rate | 24.6 | |||||
3-Year EPS without NRI Growth Rate | 28.4 | |||||
3-Year FCF Growth Rate | 27.9 | |||||
3-Year Book Growth Rate | -37.7 |
Momentum Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
9-Day RSI | 52.42 | |||||
14-Day RSI | 54.88 | |||||
12-1 Month Momentum % | 136.22 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 5.98 | |||||
Quick Ratio | 5.98 | |||||
Cash Ratio | 5.33 | |||||
Days Sales Outstanding | 139.77 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -14.4 | |||||
Shareholder Yield % | 2.81 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Operating Margin % | -8086.12 | |||||
Net Margin % | -7354.57 | |||||
FCF Margin % | -8146.92 | |||||
ROE % | -52.49 | |||||
ROA % | -31.81 | |||||
ROIC % | -64.79 | |||||
ROC (Joel Greenblatt) % | -490.98 | |||||
ROCE % | -48.6 |
GF Value Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 659.8 | |||||
PB Ratio | 5.87 | |||||
Price-to-Tangible-Book | 5.96 | |||||
EV-to-EBIT | -8.08 | |||||
EV-to-EBITDA | -9.01 | |||||
EV-to-Revenue | 662.47 | |||||
EV-to-FCF | -8.13 | |||||
Price-to-Net-Current-Asset-Value | 9.23 | |||||
Price-to-Net-Cash | 11.14 | |||||
Earnings Yield (Greenblatt) % | -12.38 | |||||
FCF Yield % | -10.44 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
PharmAbcine Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil â‚©) | 112.572 | ||
EPS (TTM) (â‚©) | -304 | ||
Beta | 1.26 | ||
Volatility % | 245.5 | ||
14-Day RSI | 54.88 | ||
14-Day ATR (â‚©) | 0.000229 | ||
20-Day SMA (â‚©) | 2915 | ||
12-1 Month Momentum % | 136.22 | ||
52-Week Range (â‚©) | 900 - 4630 | ||
Shares Outstanding (Mil) | 80.19 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
PharmAbcine Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
PharmAbcine Inc Stock Events
Event | Date | Price(â‚©) | ||
---|---|---|---|---|
No Event Data |
PharmAbcine Inc Frequently Asked Questions
What is PharmAbcine Inc(XKRX:208340)'s stock price today?
When is next earnings date of PharmAbcine Inc(XKRX:208340)?
Does PharmAbcine Inc(XKRX:208340) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |